PCRX vs SNOW · P/E 174, rev $369.8M vs rev $1.55B
Pacira BioSciences, Inc. (PCRX) versus Snowflake Inc. (SNOW) — a side-by-side from cached financials, not a winner call.
Pacira BioSciences, Inc. (PCRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Snowflake Inc. (SNOW) is a software - application company listed on US. It is led by Sridhar Ramaswamy Ph.D..
Latest reported PCRX revenue for 2026-06-30 was $369.8M. Net income was $7.6M. PCRX currently screens at market cap $890.8M and trailing P/E 174.2.
Latest reported SNOW revenue for 2026-07-31 was $1.55B. Net income was -$191.7M. Revenue was up 11.2% from 2026-04-30 to 2026-07-31. SNOW currently screens at market cap $73.90B.
PCRX currently screens at market cap $890.8M and trailing P/E 174.2. SNOW currently screens at market cap $73.90B.
Not investment advice. Open the PCRX and SNOW stock pages for the full models.
Not investment advice.